Arbutus Biopharma (ABUS) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Arbutus Biopharma (ABUS) over the last 11 years, with Sep 2025 value amounting to -$0.04.
- Arbutus Biopharma's EPS (Weighted Average and Diluted) rose 60.00% to -$0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year increase of 46.51%. This contributed to the annual value of -$0.38 for FY2024, which is 13.64% up from last year.
- Arbutus Biopharma's EPS (Weighted Average and Diluted) amounted to -$0.04 in Q3 2025, which was down 500.00% from $0.01 recorded in Q2 2025.
- In the past 5 years, Arbutus Biopharma's EPS (Weighted Average and Diluted) registered a high of $0.01 during Q2 2025, and its lowest value of -$0.24 during Q3 2021.
- In the last 3 years, Arbutus Biopharma's EPS (Weighted Average and Diluted) had a median value of -$0.10 in 2024 and averaged -$0.09.
- Over the last 5 years, Arbutus Biopharma's EPS (Weighted Average and Diluted) had its largest YoY gain of 109.09% in 2025, and its largest YoY loss of 30.00% in 2025.
- Over the past 5 years, Arbutus Biopharma's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.15 in 2021, then increased by 6.67% to -$0.14 in 2022, then increased by 14.29% to -$0.12 in 2023, then spiked by 41.67% to -$0.07 in 2024, then surged by 60.00% to -$0.04 in 2025.
- Its last three reported values are -$0.04 in Q3 2025, $0.01 for Q2 2025, and -$0.13 during Q1 2025.